Richter considering expanding range of acquisitions
Image by Richter.hu
Hungarian pharmaceutical company Gedeon Richter is mulling an expansion of its range for potential acquisitions, CEO Gábor Orbán said in an interview published in business daily Világgazdaság.
"We're looking for targets, and we even have to broaden our range of potential acquisition targets in view of royalties from our American sales partners, AbbVie," Orbán told the paper.
"In the past, we've focused more on acquiring products or portfolios and less on companies, and especially not infrastructure. Now we have to think in terms of a slightly broader range. At the moment, the management is discussing in what direction that range should be broadened," he said.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.